Published in AIDS Weekly, April 28th, 2003
Nattawan Promadej and colleagues at the Centers for Disease Control and Prevention and Emory University's Vaccine Research Center in Atlanta, Johns Hopkins University in Baltimore, and the Research Institute of Health Science in Chiang Mai, Thailand examined a cohort of HWs and their HIV-infected partners.
Virus-specific T-cell activity was less extensive in HWs compared to their seropositive partners, but was "remarkably" persistent in the absence...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.